Long-term treatment results and the immunoglobulin G subclass distribution patterns of proteinase-3-antineutrophil cytoplasm antibody (ANCA) and myeloperoxidase-ANCA in ANCA-associated vasculitis

被引:2
|
作者
Almroth, Gabriel [1 ]
Berlin, Gosta [2 ]
Andersson, Bengt [3 ]
Hahn-Zoric, Mirjana [3 ]
机构
[1] Linkoping Univ Hosp, Dept Nephrol, SE-58185 Linkoping, Sweden
[2] Linkoping Univ Hosp, Dept Clin Immunol & Transfus Med, SE-58185 Linkoping, Sweden
[3] Sahlgrens Univ Hosp, Dept Clin Immunol, S-41345 Gothenburg, Sweden
来源
关键词
ANCA; associated vasculitis; cyclophosphamide; IgG subclasses; MPO-ANCA; plasmapheresis; PR3-ANCA; pulse treatment; WEGENERS-GRANULOMATOSIS; RANDOMIZED-TRIAL; PLASMA-EXCHANGE; RENAL-DISEASE; HEPATITIS-B; AUTOANTIBODIES; ANTIGENS; EFFICACY; THERAPY;
D O I
10.1080/00365590802519354
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective. Small vessel vasculitis associated with antibodies to neutrophil cytoplasm antigens has been denominated antineutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV). Material and methods. Ninety-eight patients with various forms of AAV with renal involvement were studied retrospectively with regard to treatment, side-effects and outcome. The immunoglobulin G (IgG) subclass distribution patterns in serum were determined in 51 patients with nephelometry and those of anti-proteinase-3 (PR3) and anti-myeloperoxidase (MPO) in 44 patients by enzyme-linked immunosorbent assay. Results. Fifty-nine patients with a mean age of 63 years were given treatment with intermittent intravenous regimens of cyclophosphamide and continuous corticosteroids, whereas 39 patients with a mean age of 58 years were given continuous oral treatment. Malignancy, mainly due to skin tumours, was more common in AAV than in the general population. The total IgG subclass distribution pattern was asymmetric. The response to PR3 was of IgG1, IgG3 and IgG4 isotypes, while IgG1 and IgG3 predominated in the response to MPO. Conclusion. The aberrant IgG subclass distribution pattern detected in the autoantibodies may be of importance in the pathogenesis of AAV.
引用
收藏
页码:160 / 170
页数:11
相关论文
共 50 条
  • [1] Clinical features and prognosis of ANCA-associated vasculitis patients who were double-seropositive for myeloperoxidase-ANCA and proteinase 3-ANCA
    Yizi Gong
    Chanjuan Shen
    Ting Meng
    Wei Lin
    Xueling Hu
    Rong Tang
    Qi Xiong
    Joshua D. Ooi
    Peter J. Eggenhuizen
    Jinbiao Chen
    Ya-Ou Zhou
    Hui Luo
    Jia Xu
    Ning Liu
    Ping Xiao
    Xiangcheng Xiao
    Yong Zhong
    [J]. Clinical and Experimental Medicine, 24
  • [2] Clinical features and prognosis of ANCA-associated vasculitis patients who were double-seropositive for myeloperoxidase-ANCA and proteinase 3-ANCA
    Gong, Yizi
    Shen, Chanjuan
    Meng, Ting
    Lin, Wei
    Hu, Xueling
    Tang, Rong
    Xiong, Qi
    Ooi, Joshua D.
    Eggenhuizen, Peter J.
    Chen, Jinbiao
    Zhou, Ya-Ou
    Luo, Hui
    Xu, Jia
    Liu, Ning
    Xiao, Ping
    Xiao, Xiangcheng
    Zhong, Yong
    [J]. CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 24 (01)
  • [3] Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA
    Schönermarck, U
    Lamprecht, P
    Csernok, E
    Gross, WL
    [J]. RHEUMATOLOGY, 2001, 40 (02) : 178 - 184
  • [4] Renal Survival in Proteinase 3 and Myeloperoxidase ANCA-Associated Systemic Vasculitis
    de Joode, Anoek A. E.
    Sanders, Jan Stephan F.
    Stegeman, Coen A.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 8 (10): : 1709 - 1717
  • [5] ANTINEUTROPHIL CYTOPLASM ANTIBODY (ANCA) - LARGE-SCALE SEROLOGICAL SCREENING AND LONG-TERM FOLLOW-UP OF ANCA ASSOCIATED VASCULITIS
    MACISAAC, AI
    MORAN, JE
    DAVIES, DJ
    MURPHY, BF
    GEORGIOU, T
    NIALL, JF
    [J]. KIDNEY INTERNATIONAL, 1989, 36 (06) : 1171 - 1171
  • [6] Relapse rate and renal prognosis in ANCA-associated vasculitis according to long-term ANCA patterns
    Oristrell, J.
    Loureiro-Amigo, J.
    Solans, R.
    Valenzuela, M. P.
    Monsalvez, V.
    Segarra, A.
    Amengual, M. J.
    Marin, A.
    Feijoo, C.
    Tolosa, C.
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2021, 203 (02): : 209 - 218
  • [7] Long-term survival of ANCA-associated vasculitis
    Flossmann, Oliver
    Berden, Annelies
    De Groot, Kirsten
    Harper, Lorraine
    Heijl, Caroline
    HOGlund, Peter
    Jayne, David
    Luqmani, Raashid
    Mahr, Alfred
    Mukhtyar, Chetan
    Pusey, Charles
    Rasmussen, Niels
    Westman, Kerstin
    [J]. APMIS, 2009, 117 : 139 - 139
  • [8] Long-term rituximab for ANCA-associated vasculitis
    Thorley, Jennifer
    [J]. LANCET RHEUMATOLOGY, 2020, 2 (07): : E389 - E389
  • [9] Good long-term results for rituximab in ANCA-associated vasculitis
    [J]. Nature Clinical Practice Rheumatology, 2007, 3 (2): : 64 - 65
  • [10] Impact of different ANCA serotypes on the long-term outcome of ANCA-associated vasculitis patients
    Qi, Fumin
    Hao, Jian
    Wei, Wei
    [J]. ANNALS OF MEDICINE, 2023, 55 (02)